GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Non Operating Income

Reunion Neuroscience (TSX:REUN) Non Operating Income : C$-10.83 Mil (TTM As of Mar. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Reunion Neuroscience's Non Operating Income for the three months ended in Mar. 2023 was C$0.09 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2023 was C$-10.83 Mil.


Reunion Neuroscience Non Operating Income Historical Data

The historical data trend for Reunion Neuroscience's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reunion Neuroscience Non Operating Income Chart

Reunion Neuroscience Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Non Operating Income
0.67 -3.83 -0.21 -10.83

Reunion Neuroscience Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.61 -0.20 -8.13 -2.58 0.09

Reunion Neuroscience Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-10.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Reunion Neuroscience Non Operating Income Related Terms

Thank you for viewing the detailed overview of Reunion Neuroscience's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Reunion Neuroscience (TSX:REUN) Business Description

Traded in Other Exchanges
N/A
Address
30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3
Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.

Reunion Neuroscience (TSX:REUN) Headlines

From GuruFocus